Publications
The Case for Manufacturing Drugs in the United States Goes Back 45 Years
June 9, 2025
The Bayh-Dole Act of 1980 requires inventions made wholly or in part with federal funding to be substantially manufactured in the United States. Asher M. Rubin and Cassidy A. Pomeroy-Carter discuss how the 1980 law intended to keep drug manufacturing in the United States.
Contacts
Baltimore
+1 410 559 2881Baltimore
2850 Quarry Lake Drive, Suite 301
Baltimore, MD 21209
Capabilities
Suggested News & Insights
Sidley Advises Galvanize on US$70 Million Project Financing for AMP's AI-Powered Waste InfrastructureOctober 8, 2026Sidley Represents GE HealthCare in Its US$945 Million Acquisition of SOFIE BiosciencesOctober 7, 2026Sidley Advised Energy Transfer on US$2.625 Billion Acquisition of Vaquero MidstreamOctober 6, 2026Sidley Represents Diversis Capital in Its Acquisition of Majority Ownership of Tideworks TechnologyOctober 6, 2026Sidley Represents Telix Pharmaceuticals in Its US$1.65 Billion Merger With ITMOctober 5, 2026Sidley Represents Pyxis Oncology in an up to US$282.6 Million Public OfferingOctober 1, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory